You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Idiopathic Pulmonary Fibrosis

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Idiopathic Pulmonary Fibrosis (IPF) Trial in United States (INS018_055, Placebo)

Not yet recruiting
  • Idiopathic Pulmonary Fibrosis (IPF)
  • Los Angeles, California
  • +8 more
Jul 27, 2023

Idiopathic Pulmonary Fibrosis Trial in Los Angeles (Atezolizumab)

Not yet recruiting
  • Idiopathic Pulmonary Fibrosis
  • Los Angeles, California
    Cedars-Sinai Medical Center
Aug 23, 2022

Nintedanib Among Idiopathic Pulmonary Fibrosis Patients

Completed
  • Idiopathic Pulmonary Fibrosis
  • Milton, Massachusetts
    Medicus Economics, LCC
Aug 8, 2022

Idiopathic Pulmonary Fibrosis Trial (nalbuphine ER, Placebo)

Not yet recruiting
  • Idiopathic Pulmonary Fibrosis
  • nalbuphine ER
  • Placebo
  • (no location specified)
Jul 19, 2023

Idiopathic Pulmonary Fibrosis Trial (ARO-MMP7 Inhalation Solution, Placebo)

Not yet recruiting
  • Idiopathic Pulmonary Fibrosis
  • ARO-MMP7 Inhalation Solution
  • Placebo
  • (no location specified)
Sep 8, 2022

Idiopathic Pulmonary Fibrosis, IPF Trial in Izmir (Inspiratory Muscle Training (IMT), Sham IMT)

Completed
  • Idiopathic Pulmonary Fibrosis
  • IPF
  • Inspiratory Muscle Training (IMT)
  • Sham IMT
  • Izmir, Balcova, Turkey
    Dokuz Eylul University
Nov 6, 2022

Idiopathic Pulmonary Fibrosis Trial in Adelaide (taladegib, nintedanib)

Not yet recruiting
  • Idiopathic Pulmonary Fibrosis
  • Adelaide, South Australia, Australia
    Research Site
Apr 5, 2023

Idiopathic Pulmonary Fibrosis Trial in Paris (18FDG-PET scan)

Recruiting
  • Idiopathic Pulmonary Fibrosis
  • 18FDG-PET scan
  • Paris, France
    Service de Pneumologie A Centre constitutif de référence des mal
Oct 3, 2022

Dose Reduction and Discontinuation With Anti-Fibrotic

Not yet recruiting
  • Idiopathic Pulmonary Fibrosis
  • Ridgefield, Connecticut
    Boehringer Ingelheim
Mar 24, 2023

IPF Trial in China (PMG1015, PMG1015 )

Recruiting
  • IPF
  • Beijing, Beijing, China
  • +5 more
May 31, 2023

Idiopathic Pulmonary Fibrosis Trial in Beijing, Guangzhou, Shanghai (REGEND001 Autologous Therapy Product)

Recruiting
  • Idiopathic Pulmonary Fibrosis
  • REGEND001 Autologous Therapy Product
  • Beijing, Beijing, China
  • +2 more
Dec 19, 2022

Idiopathic Pulmonary Fibrosis (IPF) Trial in China, United States (INS018_055, Placebo)

Recruiting
  • Idiopathic Pulmonary Fibrosis (IPF)
  • Los Angeles, California
  • +9 more
Jul 6, 2023

Pulmonary Fibrosis, Interstitial Lung Disease, Lung Fibrosis Trial in Chicago

Recruiting
  • Pulmonary Fibrosis
  • +3 more
    • Chicago, Illinois
      Pulmonary Fibrosis Foundation
    Oct 28, 2022

    Idiopathic Pulmonary Fibrosis Trial in Adelaide (SRN-001, Placebo)

    Not yet recruiting
    • Idiopathic Pulmonary Fibrosis
    • Adelaide, South Australia, Australia
      CMAX Clinical Research
    Aug 2, 2023

    Idiopathic Pulmonary Fibrosis Trial in Australia, United States (PLN-74809, Placebo)

    Recruiting
    • Idiopathic Pulmonary Fibrosis
    • Redding, California
    • +15 more
    Oct 18, 2023

    All-Case Surveillance of Ofev in Patients With IPF in Japan

    Recruiting
    • Idiopathic Pulmonary Fibrosis
    • Multiple Locations, Japan
      (unnamed)
    Jan 23, 2023

    Idiopathic Pulmonary Fibrosis Trial in Shanghai (Human umbilical cord mesenchymal stem cell injection)

    Not yet recruiting
    • Idiopathic Pulmonary Fibrosis
    • Human umbilical cord mesenchymal stem cell injection
    • Shanghai, Shanghai, China
      Shanghai Sixth People's Hospital
    Jul 29, 2022

    Idiopathic Pulmonary Fibrosis, Obstructive Sleep Apnea, Gastro Esophageal Reflux Trial in Tucson (Positive Airway Pressure)

    Recruiting
    • Idiopathic Pulmonary Fibrosis
    • +2 more
    • Positive Airway Pressure
    • Tucson, Arizona
      University of Arizona
    Sep 15, 2022

    Idiopathic Pulmonary Fibrosis Trial (LTP001, Placebo, Standard of Care (SoC))

    Not yet recruiting
    • Idiopathic Pulmonary Fibrosis
    • (no location specified)
    Aug 10, 2022

    Cough, Asthma, COPD Trial (C-mo System)

    Not yet recruiting
    • Cough
    • +4 more
    • C-mo System
    • (no location specified)
    Aug 4, 2023

    Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease Trial in Kissimmee, Kansas City, Chesterfield (Inhaled Treprostinil,

    Enrolling by invitation
    • Idiopathic Pulmonary Fibrosis
    • Interstitial Lung Disease
    • Inhaled Treprostinil
    • Treprostinil Ultrasonic Nebulizer
    • Kissimmee, Florida
    • +2 more
    Jul 19, 2022

    Idiopathic Pulmonary Fibrosis Trial in Durham (Hyperpolarized 129 Xenon Gas Comparing Idiopathic Pulmonary Fibrosis (IPF)

    Recruiting
    • Idiopathic Pulmonary Fibrosis
    • Hyperpolarized 129 Xenon Gas Comparing Idiopathic Pulmonary Fibrosis (IPF) Treatment
    • Durham, North Carolina
      Duke University Medical Center
    May 3, 2022

    Idiopathic Pulmonary Fibrosis Trial in Birmingham (PET/CT using PET ligands [F-18]FDG and [F-18]DPA-714)

    Recruiting
    • Idiopathic Pulmonary Fibrosis
    • PET/CT using PET ligands [F-18]FDG and [F-18]DPA-714
    • Birmingham, Alabama
      The University of Alabama at Birmingham
    Jun 7, 2022

    Idiopathic Pulmonary Fibrosis Trial in Dijon (FMISO-PET Protocol)

    Not yet recruiting
    • Idiopathic Pulmonary Fibrosis
    • FMISO-PET Protocol
    • Dijon, France
      Chu Dijon Bourgogne
    Jul 5, 2022

    Idiopathic Pulmonary Fibrosis Trial in Australia, New Zealand (Ifenprodil)

    Completed
    • Idiopathic Pulmonary Fibrosis
    • Brookvale, New South Wales, Australia
    • +5 more
    Jul 18, 2022